1. Applications of human organoids in the personalized treatment for digestive diseases
   Qinying Wang et al, 2022, Signal Transduction and Targeted Therapy CrossRef
2. Alcolic liver disease: what’s new in the current decade?
   D. I. Trukhan, 2023, Experimental and Clinical Gastroenterology CrossRef
3. Antibiotic use and development of nonalcoholic fatty liver disease: A population‐based case–control study
   Fahim Ebrahimi et al, 2023, Liver International CrossRef
4. Impact of High-Temperature Feeds on Gut Microbiota and MAFLD
   Lijun Xue et al, 2024, Journal of Microbiology and Biotechnology CrossRef
5. Metabolic Dysfunction-Associated Fatty Liver Disease on Distinct Microbial Communities at the Bacterial Phylum Level
   Haruki Uojima et al, 2024, Digestive Diseases CrossRef
6. Sodium alginate combined with oxymatrine ameliorates CCl4-induced chemical hepatic fibrosis in mice
   Chen He et al, 2023, International Immunopharmacology CrossRef
7. Gut microbiome therapy: fecal microbiota transplantation vs live biotherapeutic products
   Do-Yeon Kim et al, 2024, Gut Microbes CrossRef
8. New Insights into the Pathogenesis of Alcoholic Liver Disease Based on Global Research
   Jinbao Zhang et al, 2025, Digestive Diseases and Sciences CrossRef